Piper Sandler Maintains Camp4 Therapeutics(CAMP.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsNov 22 07:33 ET · Ratings

Camp4 Therapeutics | 10-Q: Quarterly report

SECNov 21 16:26 ET · Announcements

Camp4 Therapeutics | 8-K: CAMP4 Reports Third Quarter 2024 Financial Results

SECNov 21 16:21 ET · Announcements

Camp4 Therapeutics Reports Q3 EPS ($24.19) Vs.($29.21) Last Year

TipRanksNov 21 16:16 ET

Express News | Camp4 Reports Third Quarter 2024 Financial Results

ReutersNov 21 16:05 ET

CAMP4 Therapeutics 3Q Loss $13.5M >CAMP

Dow JonesNov 21 16:05 ET